Table 6.
SOD and GSH-Px activities and MDA content in liver tissue (±s).
| Group | n | SOD (U/mg pro) | MDA (U/mg pro) | GSH-Px (U/mg pro) |
|---|---|---|---|---|
| Control group | 10 | 267.43±33.52 | 3.74±1.74 | 203.92±35.01 |
| CCl4-model group | 10 | 86.51±25.25# | 13.56±2.71# | 110.69±23.26# |
| Low GSP dose group | 10 | 134.74±44.82#,* | 10.73±1.41#,* | 140.29±25.41#,* |
| Moderate dose GSP group | 10 | 195.68±34.88#,*,$ | 9.03±1.64#,*,$ | 141.96±23.13#,* |
| High GSP dose group | 10 | 228.14±21.06#,*,$,& | 6.33±1.07#,*,$,& | 174.38±28.34#,*,$,& |
| DDB group | 10 | 213.47±25.12#,*,$ | 5.98±1.58#,*,$,& | 175.08±24.73#,*,$,& |
CCl4 – carbon tetrachloride; GSP – grape seed proanthocyanidins; DDB – bifendate; SOD – Superoxide dismutase; MDA – malondialdehyde; GSH-Px – glutathione peroxidase; U/mg pro – nmol min−1mg−1protein;
#
P<0.01, compared with the control group;
*
P<0.05, compared with the CCl4-model group;
$
P<0.05, compared with the low GSP dose group;
&
P<0.05, compared with the moderate GSP dose group.